バニリン架橋キトサンゲルマム膜:血液透析への応用可能性
Nabila Amalia Izaaz Aanisa1, Khabibi1, Retno Ariadi Lusiana1
1Department of Chemistry, Faculty of Sciences and Mathematics, University of Diponegoro 50275, Semarang, Central Java, Indonesia.
International journal of biological macromolecules
|February 28, 2026
まとめ
新規キトサンベース膜は、老廃物除去と血液適合性を向上させ、血液透析を改善する。これらの修飾天然ポリマーは、治療効果の向上を必要とする末期腎不全患者に有望な解決策を提供する。
科学分野:
- 生体材料科学、腎臓病学、高分子化学
背景:
- 末期腎不全(ESRD)では、代謝老廃物の除去のために血液透析が必要である。現在の血液透析膜は、血液適合性と尿毒症性毒素除去において限界に直面している。血液透析の効果を高めるためには、高度な膜材料の開発が不可欠である。
研究 の 目的:
- 新規血液透析膜の作製と評価を目的とした。膜の形態、輸送能力、血液適合性の向上を目的とした。バニリン(Va)で架橋し、ゼラチン(Gel)と混合したキトサン(Cs)ベース膜を調査した。
主な方法:
- キトサン/バニリン/ゼラチン(CVG)複合膜の作製。膜の細孔率、膨潤、吸水などの特性評価。クレアチニンおよび尿素の溶質輸送の評価。膜の親水性と血液適合性(血小板付着、溶血、凝固時間)の評価。
主要な成果:
- CVG膜は、細孔率(78.21%)、膨潤能(36%)、吸水率(89.63%)の増加を示した。クレアチニン(92.35%)と尿素(61.01%)の輸送が強化された。親水性の向上(45.89%)と、血小板付着の低減および低い溶血率(<2%)を含む顕著な血液適合性の利点が認められた。
結論:
- 開発されたCVG膜は、未修飾のCs膜と比較して優れた性能を示した。特性の向上は、血液透析応用の改善に大きな可能性を示唆している。この生体材料は、末期腎不全の治療における有望な進歩を提供する。
関連する概念動画
Dialysis
2.0K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.0K
Hemodialysis II: Procedure and Complications
1.3K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.3K
Hemodialysis I: Introduction
2.4K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.4K
Hemodialysis III: Nursing Management
1.2K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.2K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
670
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
670


